Oxeia Biopharmaceuticals
PrivateLast Round
Crowdfunding
Jan 7, 2026
Est. Valuation
$50M
Total Funding Raised
$1.98M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Oxeia Biopharmaceuticals is a clinical-stage biotechnology company developing OXE103, a therapeutic for the treatment of concussion (mild traumatic brain injury).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oxeia Biopharmaceuticals Comparables
Compare Oxeia Biopharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Astrocyte Pharmaceuticals Inc. | 83% | |
| Oragenics, Inc. | 78% | |
| Odyssey Health, Inc. | 77% |
Oxeia Biopharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Jan 7, 2026 | ||||
| Convertible Debt | Nov 18, 2025 | ||||
| Convertible Debt | Oct 2, 2023 | ||||
| Seed | Apr 2, 2015 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 53% MoM.
- May 16, 2026
Monthly visitors increased 82% MoM.
Recent news
Latest coverage and updates
- hiresSep 14, 2026
Oxeia Biopharmaceuticals, Inc. hires Smith as Board of Directors.
- is_developingSep 14, 2026
Oxeia Biopharmaceuticals, Inc. is developing OXE103 on Sep 14th '26.
- hiresJun 23, 2026
Oxeia Biopharmaceuticals, Inc. hired Don Plummer as Advisory Board on Jun 23rd '26.
Oxeia Biopharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Oxeia Biopharmaceuticals's valuation, stock price, and market status.
Is Oxeia Biopharmaceuticals a public or private company?
Oxeia Biopharmaceuticals is a private company.
What is the current stock price of Oxeia Biopharmaceuticals?
Oxeia Biopharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is Oxeia Biopharmaceuticals worth (valuation)?
Valuation information for Oxeia Biopharmaceuticals is not publicly available.
Can I buy Oxeia Biopharmaceuticals stock?
Oxeia Biopharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Oxeia Biopharmaceuticals's last funding round?
Funding round information for Oxeia Biopharmaceuticals is not publicly available.
Who are the main investors in Oxeia Biopharmaceuticals?
Investor information for Oxeia Biopharmaceuticals is not publicly disclosed.
Will Oxeia Biopharmaceuticals IPO soon?
No public IPO plans have been announced for Oxeia Biopharmaceuticals.
How can I track Oxeia Biopharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Oxeia Biopharmaceuticals's secondary market activity and sign up for updates.